Actively Recruiting
Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR"
Led by ImmunoRegister gUG · Updated on 2026-01-06
10000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
CONDITIONS
Brief Title
CEDUR - German IBD Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Crohn Disease Ulcerative Colitis Indterminate Colitis
You will not qualify if you...
- Other gastrointestinal disorders than above
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ImmunoRegister gUG
Hamburg, Germany, 20251
Actively Recruiting
Research Team
S
Stefanie Howaldt, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here